| 000 | 01654 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516223356.0 | ||
| 264 | 0 | _c20160504 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a1522-9629 | ||
| 024 | 7 |
_a10.1016/j.pupt.2014.07.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMehta, Rashmi | |
| 245 | 0 | 0 |
_aPharmacokinetics of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler. _h[electronic resource] |
| 260 |
_bPulmonary pharmacology & therapeutics _cOct 2014 |
||
| 300 |
_a66-73 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDry Powder Inhalers |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluticasone-Salmeterol Drug Combination _xadministration & dosage |
| 650 | 0 | 4 |
_aGlucocorticoids _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNebulizers and Vaporizers |
| 650 | 0 | 4 |
_aSympathomimetics _xadministration & dosage |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aDaley-Yates, Peter T | |
| 700 | 1 | _aJenkins, Kevin | |
| 700 | 1 | _aBianco, Joseph | |
| 700 | 1 | _aStylianou, Anastasia | |
| 700 | 1 | _aLouey, Margaret D | |
| 700 | 1 | _aChan, Robert H | |
| 773 | 0 |
_tPulmonary pharmacology & therapeutics _gvol. 29 _gno. 1 _gp. 66-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pupt.2014.07.001 _zAvailable from publisher's website |
| 999 |
_c24017003 _d24017003 |
||